ORIGIMM Biotechnology

Lilly CEO Reacts To CMS Alzheimer’s Coverage Decision The US Centers for Medicare and Medicaid Services (CMS) released its national coverage determination (NCD) for anti-amyloid antibodies on 11 Janua

Lilly CEO Reacts To CMS Alzheimer’s Coverage Decision The US Centers for Medicare and Medicaid Services (CMS) released its national coverage determination (NCD) for anti-amyloid antibodies on 11 Janua

1. Miserable Year For Major M&A M&A activity in 2020 was pretty quiet but positively ear-splitting compared to the first half of 2021. The lack of deals was due in no small part to the US Federal Trad